{"id":"W2045185806","doi":"10.1038/ncprheum0959","title":"Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism","year":2008,"lang":"en","type":"letter","venue":"Nature Clinical Practice Rheumatology","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Anakinra; Medicine; Canakinumab; Interleukin 1 receptor antagonist; Pharmacology; Antagonist; Blockade; Clinical trial; Receptor antagonist; Internal medicine; Immunology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001821884,0.0005755476,0.001333553,0.0001410689,0.000206879,0.00003943088,0.001059555,0.006360384,0.00005693137],"category_scores_gemma":[0.02643662,0.0004731121,0.0006180161,0.0002984983,0.0009450908,0.00002824975,0.0004585598,0.01021831,0.00004285309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005774588,"about_ca_system_score_gemma":0.0004997061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001327903,"about_ca_topic_score_gemma":0.00005898024,"domain_scores_codex":[0.9940566,0.001821119,0.00195172,0.0009778384,0.000406218,0.0007864853],"domain_scores_gemma":[0.9923765,0.003942244,0.002146412,0.001065565,0.0004149118,0.00005436627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008482875,0.0006019843,0.01329089,0.0003679168,0.001585304,0.001407827,0.001022058,0.00001163611,0.0006887261,0.00003329639,0.9724252,0.007716877],"study_design_scores_gemma":[0.001561637,0.0005973546,0.001400949,0.0002585567,0.0001496769,0.001278689,0.0009644637,0.00001337406,0.0003288091,0.00002211636,0.9928506,0.0005737475],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5567018,0.03125028,0.00006594406,0.3974885,0.008195468,0.001150542,0.00008195048,0.000070515,0.004994993],"genre_scores_gemma":[0.7201697,0.01610224,0.0005273778,0.2595791,0.0009314565,0.00006873684,0.00170991,0.0001935302,0.0007179884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1634679,"threshold_uncertainty_score":0.9997721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02092049039099148,"score_gpt":0.3411310126030737,"score_spread":0.3202105222120822,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}